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Abstract
Objectives: The purpose of this experimental in vivo investigation was to evalu-
ate the influence of modifying the implant surface by adding a monolayer of multi- 
phosphonate molecules on the de novo bone formation and osseointegration.
Material and Methods: The study was designed as an animal preclinical trial with 
intra- animal control and two healing periods, 2 and 8 weeks, to compare implants 
with an identical macro- design but with two different surfaces. Eight female Beagle 
dogs participated in the study. Control implants had a moderately rough surface 
combining sandblasting and acid etching; test implants had an additional monophos-
phonate layer covalently bonded to titanium. Histologic and radiographic (micro- CT) 
outcome variables were evaluated.
Results: The first bone- to- implant contact (fBIC) was located more coronally for the 
test implants at the first (0.065 mm (95% CI = −0.82, 0.60)) and second healing mile-
stones (0.17 mm (95% CI = −0.9, 0.55)). Most coronal BIC of the test implants dis-
played a higher percentage of osseointegration, +6.33% and +13.38% after 2 and 
8 weeks, respectively; however, the differences were not statistically significant. The 
micro- CT examination did not show any BIC difference.
Conclusions: The monophosphonate layer coating demonstrated clinical, histologi-
cal, and radiographic results similar to the control surface.
K E Y W O R D S
animal model, dental implants, histology, implant surface, osseointegration, 
monophosphonate layer, wound chamber, histometric analysis, micro- CT
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1  | INTRODUC TION
Since the first description of the osseointegration phenomenon 
(Albrektsson et al., 1981; Branemark et al., 1969, 1977), the heal-
ing of dental implants placed in alveolar bone has been extensively 
studied providing clear histological documentation on the biological 
cascade of events that guides bone and soft tissue healing around 
dental implants (Berglundh et al., ,2003, 2007). Surface treatment 
modifications have been a field of great research interest seeking 
to improve the dynamics of osseointegration and the quality and 
quantity of bone- to- implant contact (Junker et al., 2009). An in-
crease in surface roughness was the first modification that demon-
strated an increase in bone apposition (Abrahamsson et al., 2004; 
Buser et al., 1991; Wennerberg et al., 1995), and a reduced non- 
loading time between implant placement and prosthetic resto-
ration (Lazzara et al., 1998). In fact, significantly higher success 
and survival rates were reported when moderately rough surfaces 
were compared with machined surfaces (Cochran, 1999). Other 
modifications have included different surface coatings, such as hy-
droxyapatite coatings, but the latter may be infected and lead to 
unwanted tissue reactions (Abrahamsson et al., 2013; Albrektsson 
et al., 2008; van Oirschot et al., 2013; Wheeler, 1996). Research 
efforts have evolved toward modifying the chemical structure of 
titanium by incorporating fluoride ions (Ellingsen et al., 2004) or by 
augmenting the surface wettability when implants are maintained 
submerged in an isotonic NaCl solution (Buser et al., 2004). Another 
chemical surface treatment modification has been the application 
of a covalently bonded layer of monophosphonate molecules on 
titanium. The presence of Ti- O- P bound is clearly depicted by 
XPS analysis demonstrating a strong covalent bound that provides 
stability, thus producing an ultrathin layer that covers the micro- 
textured surface, which prevents the peeling off the underground 
surface, as it happens with conventional thick coatings. The aim of 
this surface treatment was to attract and stimulate bone- forming 
cells, thus providing this surface with osteoconductive properties. 
This effect has been demonstrated in vitro (Viornery et al., 2002) 
but has not been tested in oral environment in preclinical experi-
mental studies. It was, therefore, the purpose of this experimental 
in vivo investigation was to study the histological and radiographic 
response of de novo bone formation on this novel implant surface 
compared with implants with identical macro- design but without 
this very surface chemical modification.
2  | MATERIAL AND METHODS
2.1 | Study design and randomization
The study was designed as a preclinical trial with two- time healing 
periods (2 and 8 weeks after implant placement) comparing two 
implants with identical macro- design but different surface charac-
teristics. Beagle dog was chosen as experimental model. The study 
protocol consisted on four interventions: (i) tooth extraction, (ii) 
implant placement (healing T8), (iii) implant placement (healing T2), 
and (iv) euthanasia and subsequent histological processing and eval-
uation. The experimental sites were randomly allocated to either 
test or control according to a computer- generated randomization 
list (IBM SPSS Statistics® V20. JM. Domenech). Randomization se-
quence was generated using a blocking, balanced restricted rand-
omization, stratified by hemimandible and implant position (P1- P5). 
Furthermore, each hemimandible (left or right) randomly allocated 
one healing time point (T2 or T8). Allocation to the treatment was 
concealed by means of sealed envelopes containing the implant 
type, which were opened during the surgical procedure once the 
flaps were raised and the bone was exposed.
2.2 | Experimental sample
A total of eight healthy adult female Beagle one- year- old dogs (mean 
weight 14.63 kg) (Isoquimen, Barcelona, Spain) were used in this ex-
perimental in vivo investigation, in full compliance with the ARRIVE 
guidelines.
The Ethical Committee of the Jesús Usón Minimally Invasive 
Surgical Center (Cáceres, Spain) approved the study protocol (ES 
register number: 201520930011504). The animals were housed 
in the Animal experimentation Service Facility of the Jesús Usón 
Minimally Invasive Surgical Center (Cáceres, Spain), and the surger-
ies were carried out in the same premises from January 2016 to 
May 2016. All the experiments were performed according to the 
Spanish and European regulations about care and use of research 
animals; the dogs were monitored daily during the study by a vet-
erinarian accredited in laboratory animal science. According with 
animal welfare, vaccine and antiparasitic drugs were administrated 
upon arrival; they were then identified with a microchip and housed 
in pairs. Animal housing conditions were room temperature be-
tween 18 and 29°C, 30%– 70% of relative humidity, and 15 min air 
renewal per hour. A 12 hr light/dark cycle with intensity control was 
established; feeding and water intake was evaluated daily. The ex-
perimental segment of the study started after an adaptation/quar-
antine period of 3 weeks.
2.3 | Study devices
Implants were MIS® C1 implants (MIS implants technologies LTD, 
Israel), with 3.5 mm of diameter and 9 mm of length. All implants 
presented a moderately rough surface with and Sa of 1.22 ± 0.09. 
Implants presented the same macroscopic design (Figure 1h), which 
included a customized modification by creating a 0.40- mm deep 
U- shaped circumferential trough within the thread region (intra- 
osseous portion), although leaving the tip of each thread untouched 
(Figure 1i). In this manner, an experimental wound chamber was 
created following implant installation to allow for a validated study 
of the bone healing and osseointegration after implant placement 
(Abrahamsson et al., 2004; Berglundh et al., 2003).
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The surface of test implants included a covalently bonded phospho-
nate treatment that created a nanometer thin molecular nanolayer of 
monophosphonate molecules, also known as phosphonic acids (Nano 
Bridging Molecules, Gland, Switzerland), without altering the geometry 
and roughness of the implant surface. Unlike phosphates, phosphonic 
acids (phosphonates) are a family of organophosphorus compounds, 
which make them able to react and connect to the titanium oxide sur-
face. The control surface presented the conventional moderately rough 
MIS implant surface based on sandblasting and etching, without the 
monophosphonate chemical treatment. Both test and control implants 
presented the same roughness (moderately rough– Sa 1.22 ± 0.09). 
Fabrication process of the test implant surface treatment is protected 
by the patent (EP1698357), which is commercially available under the 
product name MIS B+® (MIS implants technologies LTD, Israel).
In total, 40 tests and 40 control implants were placed. From 
those, 20 test and 20 control implants were placed in the 2- week 
healing group hemimandibles and 20 test and 20 control implants 
were placed in the 8- week healing group hemimandibles. In each 
hemimandible, both test and control implants were placed according 
to random allocation in the corresponding healing period.
2.4 | Surgical procedures
All surgical interventions were performed under sterile conditions, in 
an animal operating theater and under general anesthesia induced by 
Propofol (3– 5 mg/kg/i.v., Propovet®, Abbott Laboratories, Kent, UK) 
and maintained on a concentration of 2.5%– 4% of isoflurane (Isoba- 
vet®, Schering- Plough, Madrid, Spain). The animals were first premedi-
cated with medetomidine (20 μg/kg/i.m., Domtor, Esteve, Barcelona, 
Spain) and the pain controlled with the administration of morphine 
(0.4 mg/kg/i.m., Morfina Braun 2%, B. Braun Medical, Barcelona, 
Spain). During anesthesia, the animals were continuously monitored by 
a veterinarian category B or C, controlling electrocardiography, capnog-
raphy, pulsioxymetry, and non- invasive blood pressure. Prophylactic 
administration of Cephazolin (20 mg/kg/i.v., Kurgan, Normon, Madrid, 
Spain) and Cefovezin (8 mg kg- 1 s- 1.i.d./s.c., Convenia, Zoetis, Madrid, 
Spain) was performed intraoperatively. At the end of the procedures, 
Atipamezole (50 mg/kg/i.m., Esteve, Barcelona, Spain) was adminis-
tered to revert the effects of Medetomidine. Postoperative pain was 
controlled by administration of morphine (0.2 mg/kg/i.m./6 hr, Morfina 
Braun 2% B. Braun Medical, Barcelona, Spain) and meloxicam as anti- 
inflammatory and analgesic treatment (0.2 mg/kg/i.m./SID, Metacam, 
Boehringer Ingelheim, Barcelona, Spain) for 5 days.
The surgical protocol used in this study has been was recently 
reported in detail in another publication from our research group 
(Vignoletti et al., 2019). In brief:
2.4.1 | Phase 1: tooth extraction
Extraction of mandibular 2P2, 3P3, 4P4 premolars, and the mesial 
root of 1M1 was carried out in both jaws, once teeth were hemi-
sected using a flapless procedure. (Figure 1a– c).
F I G U R E  1   Clinical stages of the experiment. (a) Baseline situation. (b) Teeth hemi- section prior to extraction. (c) Suture after teeth 
extraction. (d) Healed crest 3 months after extractions. (e) Implant osteotomies. (f) Implant placement. (g) Suture after implant placement. 
(h) Identical macroscopic design of test and control implants. (i) Wound chamber thread design; increased 0.40- mm deep U- shaped valley 
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2.4.2 | Phase 2: implant placement (8- week healing 
group)
Full- thickness buccal and lingual flaps were elevated from distal of 
the cuspid to distal of M1 and 3 mm of the alveolar ridge was ex-
posed. Once the appropriate osteotomies were done and after ran-
domization and implant allocation, implants were inserted following 
the standard manufacturing instructions. Implants were placed at 
the level of the crest (bone level), taking as reference buccal plate. 
In some of the cases, lingual aspect of the implant remained sub- 
crestally located, as the crest presented irregular shape with a more 
apical buccal bone place with respect to the lingual plate. Healing 
abutments were secured, and flaps were sutured to allow for trans-
mucosal healing. A total of five implants were placed in each hemi-
mandible following randomization. (Figure 1d– g). Postoperatively, 
the animals had professional plaque control consisting the applica-
tion of gauzes embedded in chlorhexidine solution 0.12% (Perio- 
Aid Treatment®, Dentaid, Cerdanyola del Valles, Spain) three times 
a week during the first two weeks and then 3 times a week with 
toothbrush and chlorhexidine gel. Surgeries were performed in one 
randomized (left or right) hemimandible of each dog, leaving the con-
tralateral hemimandible for the 2- week healing group). Each hemi-
mandible harbored both, test and control implants, allocated in a 
randomized sequence.
2.4.3 | Phase 3: implant placement (2- week healing 
group)
Two weeks prior to euthanasia, the same surgical procedure and 
postoperative protocol were performed in the contralateral corre-
sponding hemimandible according to the randomization sequence.
In total, 40 tests and 40 control implants were placed, 20 test 
and 20 control implants in the 2- week healing group and 20 test and 
20 control implants in the 8- week healing group.
2.4.4 | Phase 4: euthanasia
After 2 weeks of healing, dogs were first sedated with medetomi-
dine (30 μg/kg/i.m., Esteve, Barcelona, Spain) and then euthanized 
with an intravenous overdose of sodium pentobarbital (40– 60 mg/
kg/i.v., Dolethal, Vetoquinol, France). Subsequently, the lower jaws 
were dissected and retrieved with intact soft tissues and fixed in 
buffered 10% formaldehyde solution. Previous to histological pro-
cessing, the implants were individually separated using a band saw 
for micro- CT scanning.
2.5 | Micro- CT analysis
All specimens were scanned before being sectioned using a high- 
resolution micro- CT (Skyscan 1,172, Bruker micro- CT NV, Kontich, 
Belgium). The X- ray source was set at 100 Kv and 100 μA with a voxel 
size of 12 μm and an Aluminum/Copper filter (Al/Cu). Scanning was 
performed over a 360º rotation acquiring images every 0.4º. Once 
scanned, the images were reconstructed based on the Feldkamp al-
gorithm using the NRecon software (Bruker micro- CT NV, Kontig, 
Belgium). The reconstructed images were evaluated with the Data 
Viewer software (Bruker micro- CT NV, Kontig, Belgium) and rotated 
to ensure that the implant was perfectly aligned. A VOI of 4 mm of 
length was selected in the middle of the implant for all the samples, 
including all the surrounding bone in the four directions (distal, me-
sial, buccal, and lingual).
After selecting the volume of interest (VOI), data were analyzed 
using the CTAn software (Bruker micro- CT NV, Kontig, Belgium). 
Firstly, a circular VOI of 5 mm of diameter was selected. Then, im-
ages were segmented using adaptative local thresholding methods, 
selecting the best threshold parameters for bone and for implant. 
The following outcomes were measured: (a) bone- to- implant contact 
(BIC; %) expressed as 360º bone- to- implant contact (intersecting 
bone), (b) implant volume and bone volume (%) using the method 
described by Bruker in the method note (074) “Osteointegration: 
analysis of bone around a metal implant” (January 2015), expressed 
as Bone volume/Tissue volume. (Figures 2 and 3).
2.6 | Histological processing
Using a randomization protocol, half of the blocks containing the im-
plant and the surrounding hard and soft tissues were dissected and 
processed for ground sectioning following the method described by 
Donath and Breuner (Donath & Breuner, 1982). The samples were 
dehydrated in a graded series of ethanol solutions and embedded 
in a light- curing resin (Technovit 7,200 VLC; Heraeus- Kulzer GMBH, 
Werheim, Germany). To assure sectioning the implants in the longi-
tudinal axis, the resin blocks containing the implants and adjacent 
tissues were radiographed in a buccal- lingual direction and using a 
ruler and a negatoscope, pencil lines were traced over the surface 
of the block to guide the sectioning of the block with a bandsaw 
equipped with a laser- aided orientation device (Exakt Apparatebau, 
Norderstedt, Germany). After sectioning, polishing was performed 
mechanically using 1,200 and 4,000 grit silicon carbide papers 
(Struers, Copenhagen, Denmark). Finally, the blocks attained a final 
tissue thickness of about 30 μm. The slides were stained according 
to the Levai Laczkó method (Jeno & Geza, 1975).
The second half of the specimens were prepared for decalci-
fication following the “fracture technique” protocol described by 
Berglundh et al. (Berglundh et al., 1994).
2.7 | Histomorphometric analysis
The histometric evaluation was carried out using a Nikon Eclipse 
Ti microscope (Nikon, Heidelberg, Germany) equipped with image 
analysis software (Q- 500MC; Nikon). One buccolingual section per 
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implant was analyzed. All measurements were evaluated by two cali-
brated investigators masked to the specific experimental conditions 
(JS and RDR). The calibration test consisted on repeated evaluation 
of the bone- to- implant contact over the first section of each animal. 
Resulting inter- examiner intraclass correlation coefficient was 0.988 
(95% confidence intervals: 0.982– 0.999); intra- examiner intraclass 
F I G U R E  2   Two weeks healing micro- CT volumetric reconstructions
F I G U R E  3   Eight weeks healing micro- CT volumetric reconstruction and frequency distribution histogram of results
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correlation coefficients were 0.999 (95% confidence intervals: 
0.998– 1.000) for JS and 1.000 (95% confidence intervals: 0.999– 
1.000) for RDR.
The following landmarks were identified on both the buccal and 
lingual sides in each implant (Figure 4):
• Implant shoulder (I),
• The first coronal level of bone in contact with the implant (B),
• Bone crest, defined as the most coronal point of bone (Bc).
Using these landmarks, the following linear measurements were 




The percentage of bone- to- implant contact (BIC) was calculated 
along a selected surface on the buccal and lingual aspects of test 
and control implants. BIC was evaluated at the most coronal portion 
(3 mm) as well as on the entire surface (6 coronal mm) of the implant 
(Figure 5).
The area of the wound chamber was selected (Figure 6), and per-
centages of each tissue component were calculated considering the 
total wound chamber area as 100%. The areas of newly formed bone 
and parent bone were measured within the wound chamber. Three 
wound chambers (buccal and lingual) were analyzed for each implant 
(Abrahamsson et al., 2004; Berglundh et al., 2003).
2.8 | Statistical analysis
Data from both histological and micro- CT analysis were expressed 
in means (±SD), considering the dog as the statistical unit of analysis 
(n = 8). The data were tested for normality by means of a Shapiro– 
Wilk test. Comparisons between experimental/control implants 
and between 2- and 8- week healing periods were analyzed using 
the two- way ANOVA and compared using generalized estimation 
model with intragroup comparisons. Bonferroni post hoc analysis 
was further performed to evaluate differences between the time in-
tervals. Differences were considered statistically significant when p 
was <.05. This statistical analysis was performed using the software 
SPSS (SPSS® 20.0, SPSS Inc., Chicago, IL, USA).
3  | RESULTS
3.1 | Clinical findings
Healing of animals was uneventful in all dogs. All implants demon-
strated clinical signs of adequate osseointegration and were avail-
able for histological processing.
3.2 | Histological Findings
3.2.1 | Early Healing (2 weeks)
The lingual bone crest was usually positioned coronally with respect 
to the implant shoulder, while the buccal bone crest was at the same 
level, although the first bone to implant contact was located apical to 
this reference. Woven bone formation represented the main histo-
logical observation within the wound chamber area in both groups, 
F I G U R E  4   Histological landmarks: IS: Implant Shoulder. BC: 
Bone Crest. B: First bone– to- implant contact
F I G U R E  5   Histological bone to implant contact measurement. 
Coronal BIC: bone in contact with implant surface within the 
3 coronal millimeters from implant shoulder. Total BIC: bone in 
contact with implant surface within the 6 coronal millimeters from 
implant shoulder
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with this woven bone directly in contact with the implant surface. 
Fingerlike projections of woven bone were intercalated with non- 
mineralized tissue. Mature bone was observed in the thread area 
depicting areas of modeling and remodeling (Figure 7). No major dif-
ferences were observed between the groups.
3.2.2 | Late Healing (8 weeks)
There was a slight resorption of the lingual bone crest, being posi-
tioned in close proximity to the implant shoulder. Similarly, the first 
bone- to- implant contact was observed in a more coronal position 
compared with the 2- week healing sections. Woven bone had been 
substituted by lamellar bone in contact with the implant surface. 
(Figure 8).
3.3 | Histometric results
The linear vertical measurements and BIC % are reported in (Figures 
9 and 10) (Table 1). A total of 29 ground sections were available for 
analysis.
I- B. At two weeks, buccal and lingual average measurements 
showed that the first bone- to- implant contact was located 
F I G U R E  6   Wound chamber tissue area 
assessment
F I G U R E  7   Histological section of 
2- week healing implants. Note the 
discrepancy between crestal bone 
and first bone– to- implant contact 
(located apically with respect to implant 
shoulder, for both the test and control 
implants)
F I G U R E  8   Histological section of 
8- week healing implants. Note reduction 
in discrepancy between the apico- coronal 
position of the crestal bone and the 
first bone- to- implant contact in both 
implants
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approximately 0.7– 0.8 mm apical to the implant shoulder; no dif-
ferences between the groups was identified. After 8 weeks of heal-
ing, the test implants showed a significant reduction in the distance 
between implant shoulder and first bone- to- implant contact. The 
first coronal level of bone contact (B) was observed at 0.47 (SD 
0.19) and 0.64 (SD 0.19) for test and control groups, respectively. 
Differences between groups were not statistically significant.
I- Bc. Bone crest was close to implant shoulder at two weeks in 
both groups (test group, 0.08 mm SD = 0.5 versus. control group 
−0.06 mm SD = 0.28). After 8 weeks of healing, bone crest was lo-
cated at 0.37 (95% CI = 0.92, 0.18) and 0.43 mm (95% CI = 0.92, 
0.07) for the test and control groups, respectively. Intergroup differ-
ences were not statistically significant.
Bc- B. The distance between the bone crest and first bone- to- 
implant contact was reduced between 2 and 8 weeks. This reduc-
tion was as a combination of apical displacement of crestal bone and 
coronal growth of the first bone- to- implant contact. That reduction 
in distance was higher for the test (0.67 mm (95% CI = −0.16, 1.50)) 
compared with the control (0.62 mm (95% CI = −0.13, 1.37)). 
These differences between test and control were not statistically 
significant.
3.3.1 | Bone- to- implant contact (%BIC)
At two weeks, similar mean coronal BIC values were observed be-
tween groups (Table 2). An increase in mean BIC was observed after 
8 weeks in both groups. Although a higher mean BIC value was ob-
served for the test (74.84) when compared to control (59.46), this 
difference was not statistically significant.
3.3.2 | Histometrical area of tissue in the wound 
chambers (B and ST)
At 2 weeks, the mean area of newly formed bone was higher in con-
trol implants compared with test implants (33.48% SD = 12.44% ver-
sus 26.46% SD = 11.71, respectively) (Table 3). At eight weeks, newly 
formed bone area was the same between control and test implants 
(25.43% SD = 7.87% versus 26.36% SD = 8.50). Differences between 
groups were not statistically significant.
3.4 | Micro- CT results
Similar bone volume/tissue volume results were observed between test 
and control at 2 weeks (Table 4). Values increased in the same amount 
regarding test and control at 8 weeks. Around 50% of 360º radiographic 
bone- to- implant contact was observed in test and control at 2 weeks. 
A significant increase in 360º radiographic bone- to- implant contact 
was observed at 8 weeks in both, test and control implants (72.88% 
SD = 8.50% versus 70.75% SD = 7.58, respectively). Differences be-
tween groups were not statistically significant. (Figure 10).
F I G U R E  9   Graphical representation 
of linear and surface histological 
measurements
F I G U R E  1 0   Graphical representation of histological and 
radiographical bone- to- implant contact and BV/TV micro- CT 
results
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4  | DISCUSSION
The present experimental in vivo investigation was designed to 
study the histological and radiographical outcomes of a new implant 
surface treatment based on a monolayer of multi- phosphonate mol-
ecules, compared with a standard moderately rough implant surface, 
during the early and late phases of osseointegration. The novel im-
plant surface showed a more coronal first bone- to- implant contact 
and a higher amount of bone- to- implant contact in the coronal third 
of the implant to bone interface. Furthermore, the radiographic 360 
BIC percentages were superior in test group both during the early 
and late healing periods. At eight weeks, 360º BIC accounted for 
80% approximately in the test implant, while in the control implant it 
was 70% (Figure 3). Similar outcomes were observed histologically. 
However, these differences did not reach statistical significance in 
any of the time evaluations when comparing the two tested implants. 
TA B L E  1   Histometrical first bone contact distance (I- B) (mean ± SD), bone crest distance (I- BC) (mean ± SD) and first bone- to- implant 
contact to crest distance (BCB) (mean ± SD) in different groups: 2- week healing, 8- week healing in both implant groups
Group I- B 2W (mm) I- B 8W (mm) I- BC 2W (mm) I- BC 8W (mm) BCB 2W (mm)
BCB 8W 
(mm)
Test 0.77 ± 0.5 0.47 ± 0.19 0.08 ± 0.5 0.45 ± 0.24 0.69 ± 0.47 0.02 ± 0.20
Control 0.84 ± 0.54 0.64 ± 0.59 −0.06 ± 0.28 0.36 ± 0.34 0.90 ± 0.57 0.29 ± 0.67
Δ Test- Control 0.065 0.17 0.15 0.09 0.21 0.26
95% CI (−0.82– 0.69) (−0.9– 0.55) (−0.39– 0.68) (−0.42– 0.60) (−1.02– 0.60) (−1.04– 0.51)
Note: Means of buccal and lingual measurements are presented.
*Comparisons between groups (ANOVA test). p < .05. No statistically significant differences were found.
Group
BIC 3 mm 2W 
(%)
BIC 3 mm 8W 
(%)
BIC 6 mm 2W 
(%)
BIC 6 mm 8W 
(%)
Test 47.44 ± 13.81 72.84 ± 5.77 52.07 ± 14.97 73.99 ± 6.91
Control 41.11 ± 11.60 59.46 ± 14.86 46.92 ± 5.15 70.27 ± 7.94
Δ Test- Control 6.33 13.38 5.14 3.72
95% CI (−12.34– 25.00) (−4.51– 31.27) (−8.81– 19.10) (−4.51– 31.27)
Note: Means of buccal and lingual measurements are presented.
*Comparisons between groups (ANOVA test). p < .05. No statistically significant differences were 
found.
TA B L E  2   Histometrical % bone- to- 
implant contact (BIC) in the 3 and 6 
coronal mm of the implant surface in 
different groups: 2- week healing, 8- week 
healing in both implant groups
Group B 2W (%) B 8W (%) ST 2W (%) ST 8W (%)
Test 26.46 ± 11.71 26.36 ± 8.50 73.54 ± 11.71 73.63 ± 8.50
Control 33.48 ± 12.44 25.43 ± 7.87 66.52 ± 12.44 74.57 ± 7.87
Δ Test- Control 7.02 0.94 7.02 0.94
95% CI (−22.91– 8.87) (−14.29– 16.17) (−8.87– 22.91) (−16.17– 14.29)
Note: Means of buccal and lingual measurements are presented.
*Comparisons between groups (ANOVA test). p < .05. No statistically significant differences were 
found.
TA B L E  3   Histometrical % area of 
mineralized tissue (B) and % area of soft 
tissue (ST) in different groups: 2- week 
healing, 8- week healing in both implant 
groups
Group BV/TV 2W BV/TV 8W
360 BIC 2W 
(%)
360 BIC 8W 
(%)
Test 45.99 ± 9.61 61.47 ± 12.50 53.86 ± 6.94 72.88 ± 8.50
Control 46.37 ± 7.02 58.18 ± 11.35 53.85 ± 4.81 70.75 ± 7.58
Δ Test- Control 0.37 3.30 0.01 2.12
95% CI (−15.03– 14.29) (−11.36– 17.96) (−10.05– 10.08) (−7.94– 12.19)
*Comparisons between groups (ANOVA test). p < .05. No statistically significant differences were 
found.
TA B L E  4   Micro- CT radiographic bone 
volume/tissue volume (BV/TV) and % 
360º bone- to- implant contact (360 BIC) of 
the complete implant surface in different 
groups: 2- week healing, 8- week healing in 
both implant groups
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This lack of statistical significance may be due to the limited sam-
ple size, which is a regular limitation in preclinical in vivo investiga-
tions. As the present study was performed according to Spanish and 
European animal experimentation regulations, the three “Rs” prin-
ciples must be followed. The application of the reduction principle 
results in a sample limited to the minimum number of animals, gener-
ally between 6 and 8, which means that only strong differences will 
reach for statistical significance. The power obtained with eight dogs 
and the encountered effect between groups was 52.9%. To achieve 
statistical significance with eight dogs, 80% of power and 0.05 sig-
nificance level, a minimal histological difference of 1.5 mm between 
groups should have been encountered. The mild but consistent im-
provements shown in the present investigation would need a much 
more numerous animal sample to reach statistical significance.
In spite of this lack of statistically significant differences, we may 
explain the consistent better results in de novo bone apposition on 
the implant surface and degree of osseointegration measured by the 
higher percentages in BIC by the addition of phosphonates cova-
lently bonded to titanium that may exert an osteoconductive effect 
by attracting more bone- forming cells. These results coincide with 
a previously published experimental study using the same surface 
treatment in a sheep model, which reported higher removal torques 
and as higher bone to implant contact when compared with a control 
implant (von Salis- Soglio et al., 2014).
The methodology used in this investigation to evaluate the im-
pact of implant surface modifications on the early and late stages of 
osseointegration has been well validated in the scientific literature. A 
classic osseointegration preclinical study using the wound chamber 
model used in this investigation reported that implants with a mod-
erately rough surface exhibited a superior bone anchorage as com-
pared to implants with a turned surface (Abrahamsson et al., 2004). 
The implant surfaces tested in the present study had both moderate 
micro- roughness with similar Sa values, what may explain in part the 
excellent results in terms of BIC and early de novo bone formation of 
the control implants.
Modern research in implant surface technology is seeking to 
chemically modify the implant surface to make it “bioactive,” thus en-
hancing the bone healing dynamics immediately after implantation 
and facilitating early bone- to- implant contact. The addition of several 
ions incorporated in the implant surface, such as Ca, P, Sr, F, NaOH, 
and Mg, has been studied in experimental studies, reporting higher 
BIC percentages and removal torque values during early healing 
times (Albrektsson & Wennerberg, 2019). In an experimental study 
in mongrel dogs, Berglundh et al. observed a significant increase in 
BIC in the fluoride- treated implants using a similar dog experimental 
model (Berglundh et al., 2007). Similarly, Buser et al. (2004) reported 
an increase in bone- to- implant contact from 29% to 49% after two 
weeks and from 85% to 90% after eight weeks when implants with 
a moderate micro- roughness were stored in isotonic NaCl solution 
(Straumann SLActive® surface) in a minipig experimental model. 
These results were also corroborated in human histological evalua-
tion (Lang et al., 2011). The present investigation corroborated these 
results also reporting a significant increase in BIC from 2 to 8 weeks, 
data that were confirmed with the findings in micro- CT analysis. In 
fact, the differences between the test and control implants in re-
gard to the increase in bone- to- implant contact were higher at eight 
weeks, as compared to early healing. This difference may be due to 
a sustained effect of the phosphonates layer over time as a result of 
the covalent bonding with the titanium surface. Similar results were 
also reported in another experimental study evaluating the incorpo-
ration of magnesium ions to an experimental implant surface, also 
reporting a stronger bone response compared with control implants. 
The authors explained this difference by the chemical bonding pro-
moted by Mg incorporation, in spite of a surface micro- roughness 
(Sa = 0.78 µm) lower than the control implants (Sul et al., 2006).
Results from this investigation should be interpreted with cau-
tion due to the inherent limitations of this experimental model. First, 
in experimental animal studies, the bone remodeling rates are higher 
than in humans and this could lead to confusion in translating the 
healing times and the percentages of osseointegration to the clini-
cal situation. Also, as stated earlier, due to obvious ethical consider-
ations, these experimental studies have limited sample sizes, which 
may jeopardize the proper interpretation of the results. In fact, 
means in bone- to- implant contact and first bone- to- implant contact 
are superior in test implants; however, differences did not reach 
statistical significance, probably due to low sample size. Another 
possible limitation may be related to the histological assessment, as 
only one plane was studied (bucco- lingual section), hence missing 
the structural changes occurring in the mesiodistal dimension. This 
limitation, however, has been partly compensated by the micro- CT 
analysis, which assesses BIV values 360º around the implant sur-
face. It should also be noted that in spite of the utility of the wound 
chamber model to quantify the early de novo bone formation on the 
implant surface, this alteration of the implant macro- geometry does 
not exist in commercially available implants.
Although trends regarding bone formation seem promising to-
ward monophosphonate implant surface, this study failed to demon-
strate significant differences between phosphonate layer implants 
and control implants on osseointegration and position of the coronal 
bone attachment to the dental implant.
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